New model for conducting clinical trials
Apellis Pharmaceuticals turned to the Optum Digital Research Network (DRN) to help identify participants for a clinical trial of a new drug to treat a severe vision related disease that has no active treatments. The DRN shortened the identification and recruitment processes of clinical trial patients.
HOW WE HELP
Redefine the clinical trial process